Home  >  News
News
  Novartis to present 5-year data of extended phase III studies of Cosentyx in PsA & AS patients,   October 17, 2018
  Roche launches three new next-generation sequencing kits for oncology research,   October 16, 2018
  ACG group consolidates its multiple business and regional brands into a single new ACG identity,   October 16, 2018
  IAMAI sees e-pharmacy rules to bring positive change in healthcare ecosystem,   October 16, 2018
  PRC NMPA approves JHL Biotech's phase I and phase III clinical trial application for biosimilar JHL1149 to treat cancer,   October 16, 2018
  Alembic Pharma gets US FDA tentative approval for Alogliptin tablets,   October 16, 2018
  Infusion Nurses Society focuses on Standardise Infusion Therapy to ensure patient safety,   October 16, 2018
  Sysmex Inostics' study in Journal of Molecular Oncology highlights clinical value of blood-based ctDNA mutation testing in melanoma treatment,   October 16, 2018
  Medlife awarded India’s best pharma delivery e-Platform company by Frost and Sullivan in 2018,   October 16, 2018
  Mylan Pharmaceuticals attracts 200 participants from 44 cities for its Hackathon event to address health challenges,   October 16, 2018
  Bluegrass Vascular completes enrollment of international SAVE registry with positive results,   October 16, 2018
  Premier Health Group selects Reliq Health Technologies as technology partner for their HealthVue Clinics,   October 16, 2018
  Hemogenyx's subsidiary Immugenyx inks collaboration deal with Janssen Research & Development,   October 16, 2018
  Targovax announces encouraging disease-free survival data from Tg01 clinical trial in resected pancreatic cancer,   October 16, 2018
  Teva Pharmaceutical launches patient-centric website 'Life Effects' in Europe,   October 16, 2018
  PureTech’s Karuna initiates phase 2 study of KarXT for treatment of Schizophrenia,   October 16, 2018
  EMA's COMP issues positive opinion on orphan drug status for Santhera's POL6014 to treat cystic fibrosis,   October 16, 2018
  Bristol-Myers Squibb's phase 3 CheckMate-331 study does not meet primary endpont,   October 15, 2018
  Dr Reddy's Laboratories announces sale of its API manufacturing unit in Jeedimetla,   October 15, 2018
  Bayer's Xarelto receives US FDA nod to treat coronary artery disease,   October 15, 2018

 Back
 
ipc_2018
cphi-india_Banner-150x60
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |